J&J | JNJ - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
AbbVie USD 14.39B 1.85B 2026-06
Abbott USD 6.65B 787M 2026-06
Amgen USD 5.87B 1.02B 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Baxter International USD 1.14B 251M 2026-06
Bayer EUR 8.17B 1.24B 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Biogen USD 2.12B 307M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
CONMED USD 197.46M 14.01M 2026-06
Cooper Companies USD 735.4M 40.2M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Globus Medical USD 496.26M 39.69M 2026-03
Insulet USD 562.6M 21.8M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
J&J USD 18.55B 1.31B 2026-06
Medtronic USD 6.01B 595M 2026-03
Merck USD 12.09B 1.24B 2026-03
Merit Medical Systems USD 215.17M 30.37M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
Stryker USD 4.5B 688M 2026-06
Tandem Diabetes Care USD 136.79M 30.67M 2026-03
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06
Zoetis USD 1.62B 20M 2026-03